Ropes & Gray represented Sands Capital in leading $100 million in Series D financing for Cytovale, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases.

Sands Capital is an active, long-term investor in leading innovative businesses globally. The firm managed more than $53.9 billion in client assets as of Sept. 30.

The team was led by venture capital & emerging companies partner Brad Flint.